Bionik Laboratories Corp.
BNKL
Other OTC0.00
USD
- -
- -
CIK
0001508381
ISIN
US09074A2087
CUSIP
09074A208
Return %
Stock
S&P500
1Y
0.00
18.46
3Y
-99.97
64.72
5Y
-99.99
72.79
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Richard Paul Russo Jr.
- Full Time Employees
- 12
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 80 Coolidge Hill Road Watertown MA United States of America 02472
- IPO Date
- Mar 5, 2015
- CIK
- 0001508381
- Website
- bioniklabs.com
- Similar Companies
- Business
- Bionik Laboratories Corp. is a robotics company specializing in neurological functional recovery solutions aimed at stroke survivors and individuals with mobility impairments due to neurological conditions. The company designs, develops, and commercializes physical rehabilitation technologies featuring its core product line of InMotion robotic devices. These include the InMotion ARM, InMotion ARM/HAND, and other robotic systems providing therapy for upper extremity motor control and rehabilitation. The technologies offer patient-adaptive therapy, objective evaluation assessments, and data-driven rehabilitation designed to restore motor function. Bionik operates Neuro-Recovery Centers of Excellence and provides its technology both directly to therapists and through clinical centers, with ongoing product development including a home-use version of the InMotion technology and an assistive wearable lower-extremity device based on the ARKE exoskeleton technology. Founded in 2010 and headquartered in Boston, Massachusetts, Bionik serves healthcare providers, rehabilitation centers, and patients across multiple countries, with its InMotion technologies currently used in over 20 countries. The company caters largely to hospitals and rehabilitation facilities, including strategic partnerships to enhance patient access and clinical outcomes. In recent years, Bionik has expanded its partnership with Lifepoint Health, installing InMotion ARM robotic devices in multiple rehabilitation hospitals across the United States, including locations in Arizona, California, Indiana, and Kentucky. This partnership has grown to over 30 Lifepoint Health facilities as of 2023, facilitating advanced stroke recovery care and hospital staff training. Bionik also entered a distribution agreement with Pro-Med Technology for sales in Hong Kong and showcased its robotic rehabilitation devices at international medical trade shows such as KIMES. Most recently in 2024, Bionik launched an improved InMotion Arm interactive robotic system to deliver enhanced clinical rehabilitation for stroke and neurological patients. Additionally, Bionik has reported increased patient volume at its acquired rehabilitation center in Florida and secured a U.S. patent for innovative rehabilitation technology. The company continues strategic growth through its Neuro-Recovery Centers and ongoing product development pipeline.
Bionik Laboratories Granted United States Patent for Innovative Rehabilitation Technology
Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong
BIONIK Laboratories to Present at National Investment Banking Association Conference